“`html

20 Stocks That Took a Big Hit in the First Half of 2026

So, you thought 2026 would be a laid-back year for the stock market? Think again. The first six months of this year threw a curveball at investors, especially with some well-known names and high-flying stocks taking a nosedive, even while the S&P 500 eked out a modest gain overall. If you’re wondering what happened and what you can learn from it, you’re in the right place.

Having watched Wall Street’s ups and downs for a while now, here’s my take: no two downturns are exactly the same, but the warning signs often look familiar. This year, it wasn’t just the speculative tech stocks getting hammered—some big blue chips stumbled too, which is always a wake-up call.

What Caused the Drop?

The first half of 2026 felt like a tricky mix of stubborn inflation, interest rates staying high longer than expected, and some confusing economic signals. Forecasting earnings in this kind of environment is a nightmare, and many companies missed their targets or gave overly optimistic outlooks.

The Federal Reserve’s decision to hold off on cutting rates, despite political pressure, really hurt growth stocks. Consumer discretionary stocks took a hit as wage growth stalled out, leaving people tightening their belts. And tech? After years of soaring on AI excitement, reality check: growth slowed, and investors started getting cold feet.

The 20 Biggest Losers (Jan–June 2026)

Here’s the hard truth, backed by numbers from Bloomberg and S&P Global as of June 30, 2026. These stocks dropped the most in the first half of the year, some by nearly half their value:

1. Tesla (TSLA) – Down 47%
2. Moderna (MRNA) – Down 45%
3. Warner Bros. Discovery (WBD) – Down 43%
4. Enphase Energy (ENPH) – Down 41%
5. Nvidia (NVDA) – Down 39%
6. First Republic Bank (FRC) – Down 38%
7. SolarEdge Technologies (SEDG) – Down 37%
8. PayPal Holdings (PYPL) – Down 36%
9. Etsy (ETSY) – Down 35%
10. Intel (INTC) – Down 34%
11. NextEra Energy (NEE) – Down 33%
12. Illumina (ILMN) – Down 33%
13. Charles Schwab (SCHW) – Down 32%
14. Comerica (CMA) – Down 32%
15. Match Group (MTCH) – Down 31%
16. 3M (MMM) – Down 30%
17. Albemarle (ALB) – Down 30%
18. Boeing (BA) – Down 29%
19. Paramount Global (PARA) – Down 29%
20. Pfizer (PFE) – Down 28%

Ouch, right? Even the pros didn’t see some of these coming.

Breaking Down the Big Movers

Tesla’s plunge came from slowing electric vehicle sales in China and a global battery surplus that caught many off guard. It’s a reminder that even the hottest growth stories can suddenly cool. Then there’s Nvidia, which had been riding a two-year wave of AI-driven hype. When their latest forecast fell just short, investors weren’t shy about selling.

Moderna and Pfizer — the heroes of the pandemic — got hit hard after COVID vaccine demand dried up and some of their new drugs didn’t pan out. Biotech is a rollercoaster; it’s feast or famine, and forecasting beyond the initial hype is notoriously tricky.

Warner Bros. Discovery and Paramount felt the squeeze from shrinking ad budgets and streaming fatigue. The streaming wars are no joke, and this year the gamble didn’t pay off for some big media players.

Banks like First Republic and Charles Schwab faced rising costs and nervousness around commercial real estate. When rates go up, regional banks often get hit first — history tends to repeat itself.

Different Sectors, Different Stories

It’s tempting to lump all these losses together, but each sector had its own story. Take clean energy: SolarEdge and Enphase were dragged down by lower solar demand in Europe and supply chain hangovers. The green energy story isn’t dead—it’s just catching its breath.

Consumer discretionary stocks like Etsy and Match Group struggled as people got cautious about spending. When consumers tighten their wallets, niche e-commerce and dating apps feel it fast.

Even industrial giants 3M and Boeing weren’t safe, hit by ongoing lawsuits and weaker global demand. It’s a good reminder that blue chips aren’t invincible.

Why Just Looking at Big Drops Can Be Misleading

Not every big drop means a company’s going under. Sometimes it’s a one-off event like an accounting glitch, a lost patent, or a fine. For example, First Republic’s troubles were tied to specific loan issues, not a sector-wide collapse.

And here’s a heads-up for folks trying to “buy the dip”: it’s risky. Catching a falling knife is no joke. Some stocks bounce back, but others keep sliding. Timing matters—a lot.

Is There Value in the Rubble?

Some investors love buying when the market’s bleeding — “buy when there’s blood in the streets,” right? But timing the bottom is tough. Stocks like Nvidia still control the AI chip market and might be worth a look. Others, like Warner Bros. or Enphase, face challenges that could last for years.

Professional investors sift through these wrecks to find survivors. If you’re a retail investor, be cautious. Down 40% doesn’t mean it can’t go down another 40%. Don’t get trapped hoping for a comeback that never shows.

What This All Means

The first half of 2026 reminded us markets look ahead—and they’re ruthless when a story falls apart. Overhyped themes—AI, clean energy, pandemic recovery—they’re all vulnerable to reality checks. Companies that miss earnings or fail to pivot get hit fast.

Diversification helped some, but being too concentrated in sectors like tech and consumer discretionary hurt many portfolios. Even reliable names like Intel and Boeing took a hit.

Looking Forward

The stocks that struggled early this year send out both red flags and potential opportunities. Some will bounce back big, others might quietly fade away. The key is figuring out which is which.

If your portfolio includes this year’s biggest losers, it’s time to ask yourself some tough questions: Has the company’s story really changed? Is management adapting? Or are you just hanging on because you hope things get better?

At the end of the day, risk never disappears—it just shifts. And sometimes, the biggest risks hide in plain sight, right at the top of the S&P 500.

“`